strategy antivirus drug discovery lucid limit viral interfere meghan hiv patient benefit connect gb virus c gbc since hivposit individual longterm viraemia show better survive rate without persist direct influence replica shown expert human nonpathogen member flavivirida family replica b cell therefore share partly ecology inch earlier work demons recombin glycoprotein e peptide derive terminus interfere entry studi investing under meghan perform viruses fusion assay temperaturearrest hivinfect kinen provide revid hivinhibitori late step engage gp cd receptor receptor bind competed reveal termini bind disulfide loop region transmembrane protein conduct compute analyst identify sequence similar termini similar appear enable interact crucial domain involve gpp interface furthermore result present init proof concept target abl inhibit inspire develop new class inhibitor 